Results 141 to 150 of about 19,697 (197)

Novel Missense Variants in <i>TRIM37</i> Associated with Mulibrey Nanism and Complex Congenital Heart Disease. [PDF]

Cardiol Cardiovasc Med
Zodanu GKE, Zeigler AC, Mudery J, Wolf C, Hwang JH, Kang X, Speirs A, Wang LK, Biniwale R, Si MS, Halnon N, Satou GM, UCLA Congenital Heart Defects BioCore Faculty, Grody WW, Van Arsdell GS, Nelson SF, Touma M.   +16 more
europepmc   +1 more source

Comprehensive Genomic Characterization of m⁶A Methylation Machinery and Its Cadmium-Responsive Expression Profiles in Pepper (<i>Capsicum chinense</i>). [PDF]

Int J Mol Sci
Xu H, Li W, Wang Y, Bao W.
europepmc   +1 more source

Mechanism of and research progress on alterations in the RET gene in thyroid cancer (Review). [PDF]

Mol Med Rep
Wei M, Wang R, Qian J, Fang Q, Tao J.
europepmc   +1 more source

TRIM28 orchestrates SUMO-ubiquitin crosstalk to stabilize PPARG and drive bladder cancer progression. [PDF]

Cell Death Dis
Fan X, Li Z, Gao Q, Huang P, Li Z, Lu D, Wang L, Xiang P, Huang T, Shen D, Xiao J.   +10 more
europepmc   +1 more source

TRIM46 deficiency‑induced DNA damage enhances the sensitivity of cisplatin in non‑small cell lung cancer by regulating the Akt signaling pathway. [PDF]

Oncol Rep
Jin S, Zhang D, Liao Z, Yu L, Wang Y, Jia P, Pan M, Li Y, Zhang J.   +8 more
europepmc   +1 more source

Silymarin alleviates cisplatin-induced cachexia via modulating tripartite motif containing 63 (TRIM63) and myogenin.

Indian J Pharmacol
Das S, Jyotika, Pahuja R, Kushwaha S, Shrivastava R.   +4 more
europepmc   +1 more source

All hands on DEK: structural insights into a unique histone modifier and chromatin remodeler. [PDF]

Epigenetics Chromatin
Peters EJ, Gardner KL, Privette Vinnedge LM.   +2 more
europepmc   +1 more source

PLLP inhibits the progression of WT p53 gastric cancer by reducing p53 protein ubiquitination by binding to TRIM59. [PDF]

J Biol Chem
Quan Z, Lin L, Xu F, Zhou C, Huang R, Sun K, Jiang H.   +6 more
europepmc   +1 more source

Serum heat shock protein family A member 9 protein as a biomarker for bortezomib resistance and poor prognosis in patients with multiple myeloma. [PDF]

Anticancer Drugs
Chen L, Gao S, Lin L, Liu S, Ma J, Zhang Z, Li Q.   +6 more
europepmc   +1 more source

TRIM47: molecular characteristics, disease-related mechanisms, and clinical translational value. [PDF]

Front Immunol
Wang Q, Zhuo X, Wang X, Luo T, Yin J.
europepmc   +1 more source